Kenneth P Jarvis

Learn More
PURPOSE To evaluate the preclinical pharmacokinetics, antitumor efficacy, and mechanism of action of a novel orally active farnesyltransferase inhibitor, ABT-100. EXPERIMENTAL DESIGN In vitro(More)
  • 1